Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Aims: To synthesize data on the worldwide prevalence and severity of COPD by geographical region, age groups, and smoking status in a systematic review. Methods: A systematic search was performed following Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. International databases including PubMed, Scopus and Web of Science were searched for population-based studies published between January 2004 and May 2015 that reported the prevalence of COPD anywhere in the world. The prevalence of COPD was calculated based on World Health Organization (WHO) regions and sex and severity stages using metaprop. Meta-regression and subgroup analysis were applied to determine the sources of heterogeneity. Results: Sixty papers were screened with a combined subject sample size of 127 598. The prevalence of post-bronchodilator COPD was 12.16% (10.91-13.40%). The pooled prevalence of COPD was 15.70% (13.80-18.59%) in men and 9.93% (8.73-11.13%) in women. Among all WHO regions, the highest prevalence was recorded in the Region of the Americas (14.53%), and the lowest was recorded in the South-East Asia Region/Western Pacific Region (8.80%). Meta-regression model variables were: sample size, WHO region, study quality score, level of gathering data, publication year, and sampling methods that justified 29.82% of heterogeneity detected among COPD prevalence rates worldwide. Conclusions: Global prevalence of COPD among men is about 5% higher than among women. The most prevalent stage of COPD is stage 1.

<p>Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources</p>

“…This prevalence was higher than the corresponding prevalence of 9.9% and 15.7% reported in a recent global systematic review. 25 In this review, COPD was defined by post-bronchodilator FEV 1 /FVC <0.7. We used pre-bronchodilator spirometry, and that might partly explain the higher prevalence.…”

<p>Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study</p>

“…[5][6][7][8] In addition, AECOPD has a high economic and social cost and is associated with high morbidity and mortality. 9 The clinical manifestations and prevalence of COPD are variable, 10,11 which may be related to differences in the level of economic development between provinces and the degree of exposure to risk factors. 12 Therefore, further research on the management of COPD is needed to determine disease characteristics and risk factors.…”

<p>Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany</p>

“…This is an important consideration, given that COPD is more prevalent in older populations. 18,19 As elderly patients are typically underrepresented in clinical trials, 20 extrapolation of these DCE findings to older patients with COPD in real-world clinical practice should be approached with caution.…”